Home
About
FAQ
History (11)
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
Helping Older Adults Improve Their Medication Experience (HOME) by Addressing Medication Regimen Complexity in Home Healthcare.
Moore, Laura
Clinical and consumer trial performance of a sensitive immunodiagnostic home test that qualitatively detects low concentrations of sperm following vasectomy.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (66)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
Herbert L. Bonkovsky MD
Wake Forest School of Medicine
Why?
Jason M. Grayson PhD
Wake Forest School of Medicine
Why?
Pierre L. Triozzi MD
Wake Forest School of Medicine
Why?
Martha A. Alexander-Miller PhD
Wake Forest School of Medicine
Why?
Mercedes Porosnicu MD
Wake Forest School of Medicine
Why?
Marlena M. Westcott PhD
Wake Forest School of Medicine
Why?
Douglas S. Lyles PhD
Wake Forest School of Medicine
Why?
Frank C. Marini PhD
Wake Forest School of Medicine
Why?
Karen M. Haas PhD
Wake Forest School of Medicine
Why?
Carl D. Langefeld PhD
Wake Forest School of Medicine
Why?
Peter E. Clark MD
Wake Forest School of Medicine
Why?
Timothy D. Howard PhD
Wake Forest School of Medicine
Why?
Bruce A. Lessey MD, PhD
Wake Forest School of Medicine
Why?
Michael T. Brennan DDS, MHS
Wake Forest School of Medicine
Why?
Ralph B. D'Agostino PhD, FASA
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 5
Next
Prev
Search Criteria
Interferons
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions